ATE542896T1 - Mit dpp-iv hemmenden peptiden angereichertes proteinhydrolysat und deren verwendung - Google Patents

Mit dpp-iv hemmenden peptiden angereichertes proteinhydrolysat und deren verwendung

Info

Publication number: ATE542896T1
Authority: AT; Austria
Prior art keywords: dpp; protein hydrolyzate; protein hydrolysate; inhibiting peptides; enriched
Prior art date: 2004-12-23

Application number

AT05809074T

Other languages

English (en)

Inventor

Jan-Willem Pieter Boots

Original Assignee

Campina Nederland Holding Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-12-23

Filing date

2005-11-30

Publication date

2012-02-15

2005-11-30 Application filed by Campina Nederland Holding Bv filed Critical Campina Nederland Holding Bv

2012-02-15 Application granted granted Critical

2012-02-15 Publication of ATE542896T1 publication Critical patent/ATE542896T1/de

Links

108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
239000003531 protein hydrolysate Substances 0.000 title abstract 4
108010067722 Dipeptidyl Peptidase 4 Proteins 0.000 title abstract 3
102100025012 Dipeptidyl peptidase 4 Human genes 0.000 title abstract 3
230000002401 inhibitory effect Effects 0.000 title abstract 2
102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
108010009736 Protein Hydrolysates Proteins 0.000 abstract 3
208000008589 Obesity Diseases 0.000 abstract 1
150000001413 amino acids Chemical class 0.000 abstract 1
235000013361 beverage Nutrition 0.000 abstract 1
235000015872 dietary supplement Nutrition 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
235000013305 food Nutrition 0.000 abstract 1
239000000413 hydrolysate Substances 0.000 abstract 1
208000026278 immune system disease Diseases 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
230000001404 mediated effect Effects 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
235000020824 obesity Nutrition 0.000 abstract 1
125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
238000011282 treatment Methods 0.000 abstract 1
208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/005—Enzyme inhibitors
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
- A23J1/202—Casein or caseinates
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
- A23J1/205—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey from whey, e.g. lactalbumine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4717—Plasma globulins, lactoglobulin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
- C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/54—Proteins
- A23V2250/548—Vegetable protein
- A23V2250/5488—Soybean protein

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Zoology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Wood Science & Technology (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Microbiology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
General Engineering & Computer Science (AREA)
Hematology (AREA)
Obesity (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Child & Adolescent Psychology (AREA)

AT05809074T 2004-12-23 2005-11-30 Mit dpp-iv hemmenden peptiden angereichertes proteinhydrolysat und deren verwendung ATE542896T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP04078502		2004-12-23
PCT/NL2005/050056 WO2006068480A2 (en)	2004-12-23	2005-11-30	Protein hydrolysate enriched in peptides inhibiting dpp-iv and their use

Publications (1)

Publication Number	Publication Date
ATE542896T1 true ATE542896T1 (de)	2012-02-15

Family

ID=36602170

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT05809074T ATE542896T1 (de)	2004-12-23	2005-11-30	Mit dpp-iv hemmenden peptiden angereichertes proteinhydrolysat und deren verwendung

Country Status (9)

Country	Link
US (2)	US8273710B2 (de)
EP (1)	EP1831361B1 (de)
JP (1)	JP5068174B2 (de)
KR (1)	KR101331777B1 (de)
AT (1)	ATE542896T1 (de)
DK (1)	DK1831361T3 (de)
ES (1)	ES2381118T3 (de)
TW (1)	TWI421089B (de)
WO (1)	WO2006068480A2 (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR101331777B1 (ko)	2004-12-23	2013-11-21	캄피나 네덜란드 홀딩 베.붸.	Ｄｐｐ-ｉｖ를 억제하는 펩타이드가 풍부한 단백질가수분해물 및 이의 용도
US20100056458A1 (en) *	2005-06-30	2010-03-04	Campina Nederland Holding B.V.	Peptides Inhibiting Angiotensin-Converting Enzyme
JP2009517464A (ja)	2005-11-30	2009-04-30	カンピーナネーダーランドホールディングビー．ブイ．	グルカゴン様ペプチド１の活性を増強するタンパク質加水分解物の使用
EP1840133A1 (de) *	2006-03-29	2007-10-03	Global Biotech Development Corp. Ltd.	Neue immunomodulierende Oligopeptide
CA2649842C (en) *	2006-04-21	2015-02-17	Meiji Seika Kaisha, Ltd.	Composition containing peptide as active ingredient
AU2007244352B2 (en) *	2006-04-28	2013-09-26	Megmilk Snow Brand Co., Ltd.	Peptide
JP2008189637A (ja) *	2007-02-08	2008-08-21	Snow Brand Milk Prod Co Ltd	自己免疫疾患予防剤
GB2451858A (en) *	2007-08-15	2009-02-18	Sergiy Konovchuk	Methods of reducing body fat and treating obesity
AU2008297541A1 (en) *	2007-09-11	2009-03-19	Mondobiotech Laboratories Ag	Use of a peptide as a therapeutic agent
WO2009128713A1 (en) *	2008-04-14	2009-10-22	Newtricious B.V.	Egg protein hydrolysates
DE102008062136B4 (de) *	2008-12-16	2012-05-03	Kamamed Ug	Pharmazeutische Zusammensetzung auf Basis von Peptid aus Kamelmilch
US20100210564A1 (en) *	2009-02-02	2010-08-19	Kyoto University	Drug or food containing a peptide
JP5735734B2 (ja) *	2009-04-16	2015-06-17	雪印メグミルク株式会社	脂質代謝改善剤
JP2011084485A (ja) *	2009-10-13	2011-04-28	Snow Brand Milk Prod Co Ltd	脂肪蓄積抑制剤
AU2011221270A1 (en) *	2010-02-24	2012-09-13	Morinaga Milk Industry Co.,Ltd.	Therapeutic agent for eating disorders
MX2012013069A (es) *	2010-05-12	2013-01-24	Mapi Pharma Ltd	Polimorfos de benzoato de alogliptina.
JP5927191B2 (ja) *	2010-08-24	2016-06-01	武▲漢▼九生堂生物工程有限公司	全卵タンパク質ペプチド、その調製方法及び使用
CN105833256A (zh) *	2012-03-09	2016-08-10	森永乳业株式会社	二肽基肽酶iv抑制剂
WO2013133032A1 (ja) *	2012-03-09	2013-09-12	森永乳業株式会社	ジペプチジルペプチダーゼ－ｉｖ阻害剤
WO2014060495A1 (en) *	2012-10-19	2014-04-24	Dsm Ip Assets B.V.	Process for the production of an infant formula
CN103232526B (zh) *	2012-12-12	2015-06-24	上海交通大学	一种生物活性多肽lplp及其制备和应用
US9345727B2 (en)	2013-03-15	2016-05-24	Mead Johnson Nutrition Company	Nutritional compositions containing a peptide component and uses thereof
US8889633B2 (en)	2013-03-15	2014-11-18	Mead Johnson Nutrition Company	Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9352020B2 (en) *	2013-03-15	2016-05-31	Mead Johnson Nutrition Company	Reducing proinflammatory response
US9289461B2 (en)	2013-03-15	2016-03-22	Mead Johnson Nutrition Company	Reducing the risk of autoimmune disease
US9138455B2 (en)	2013-03-15	2015-09-22	Mead Johnson Nutrition Company	Activating adiponectin by casein hydrolysate
US9345741B2 (en)	2013-03-15	2016-05-24	Mead Johnson Nutrition Company	Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
WO2014199780A1 (ja) *	2013-06-12	2014-12-18	マルハニチロ株式会社	ジペプチジルペプチダーゼｉｖ（ｄｐｐｉｖ）阻害ペプチド化合物、それを含有する組成物、及びその製造方法
CN103483418B (zh) *	2013-09-12	2015-04-01	陈尚武	一种dpp-ⅳ抑制多肽及其应用
US10639334B2 (en) *	2014-01-07	2020-05-05	Mead Johnson Nutrition Company	Pediatric nutritional composition with milk peptides for healthy growth and development
FR3017536B1 (fr)	2014-02-18	2017-05-26	Univ La Rochelle	Compositions pour la prevention et/ou le traitement de pathologies liees a l'alpha-glucosidase
JP5872725B1 (ja) *	2015-02-26	2016-03-01	ヤマキ株式会社	鰹節由来のジペプチジルペプチダーゼｉｖ阻害組成物
JP2017031105A (ja) *	2015-08-03	2017-02-09	森永乳業株式会社	食後血糖値の上昇抑制を促進させる剤
CN105341949B (zh) *	2015-10-09	2018-03-27	滨州万嘉生物科技有限公司	一种具有降血糖功能的鱼肉蛋白肽及其制备方法与应用
EP3397078A1 (de)	2015-12-28	2018-11-07	Abbott Laboratories	Nahrungsmittelzusammensetzungen mit hydrolisiertem protein und modifiziertem fettsystem sowie verwendungen davon
CN110381964A (zh) *	2017-03-03	2019-10-25	森永乳业株式会社	Glp-1分泌促进剂和组合物
EP3596103A4 (de) *	2017-03-16	2021-01-20	Microsintesis Inc.	Zusammensetzungen und verfahren mit probiotischen molekülen
KR20190140443A (ko)	2017-03-16	2019-12-19	마이크로신테시스 인크.	병원균 병독성을 감소시키는 프로바이오틱 분자
CN108314705B (zh) *	2018-01-26	2020-07-14	海普诺凯营养品有限公司	具有dpp-iv抑制功能的羊乳清蛋白肽、其制备方法及其应用
CN108935912B (zh) *	2018-06-21	2021-04-23	中国农业大学	一种具有dpp-ⅳ抑制和抗疲劳功能的鱼肉蛋白肽及其制备方法
JP7068942B2 (ja) *	2018-06-25	2022-05-17	サンスター株式会社	トリペプチド含有組成物
WO2021083958A1 (en) *	2019-10-29	2021-05-06	Specialites Pet Food	Novel peptides inducing satiety
CN114621320B (zh) *	2020-12-14	2024-05-24	清华大学	一种可用于减缓glp-1酶解的短肽及其组合物
WO2022186290A1 (ja) *	2021-03-02	2022-09-09	森永乳業株式会社	ジペプチジルペプチダーゼ－ｉｖ阻害剤
CN113035291B (zh) *	2021-04-08	2022-04-05	广东药科大学	计算机辅助药物设计dpp-iv抑制肽的方法、dpp-iv抑制肽及其应用
CN113480605A (zh) *	2021-07-27	2021-10-08	中国海洋大学	一种牦牛乳酪蛋白dpp-iv抑制肽及其筛选方法
JP2023069271A (ja)	2021-11-05	2023-05-18	住友化学株式会社	Ｄｐｐ－４阻害剤およびその製造方法。
CN114686551B (zh) *	2022-03-16	2023-08-08	江南大学	一种豌豆蛋白源dpp-iv抑制肽及其筛选方法
CN114836491B (zh) *	2022-05-30	2023-03-14	广州恒雅生物化工有限公司	一种抗老亮肤的肌肽制备方法及其在化妆品的应用
JP7847653B2 (ja) *	2022-08-19	2026-04-17	森永乳業株式会社	組成物
CN115252759A (zh) *	2022-08-24	2022-11-01	四川大学华西第二医院	酸奶衍生多肽在制备延缓端粒缩短药物及抗衰老药物中的应用
CN116284234B (zh) *	2023-02-09	2024-11-08	昆明理工大学	一种驼乳源小分子肽及其应用
CN117598389A (zh) *	2023-11-13	2024-02-27	大连工业大学	一种具有增强免疫功能的酪蛋白水解物及其制备方法
CN118620029B (zh) *	2024-05-27	2024-12-20	合肥工业大学	一种干腌火腿源dpp-iv抑制肽及其制备、鉴定方法和应用
CN118894920B (zh) *	2024-10-09	2025-04-04	澳优乳业（中国）有限公司	一种具有降血糖作用的功能肽及制备方法和应用
CN120098106B (zh) *	2025-05-08	2025-08-22	华南理工大学	一种酪蛋白源降血糖肽及其应用
CN120718130B (zh) *	2025-08-15	2025-12-30	杭州康源食品科技有限公司	一种促钙吸收利用的酪蛋白源七肽及其应用

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5681586A (en)	1989-03-23	1997-10-28	Gordon; Arthur L.	Enzyme-modified soy and soy/casein combination healing compositions
JP3119674B2 (ja) *	1991-02-15	2000-12-25	日本合成化学工業株式会社	新規ペプチド、その製造法及び用途
DE4211878C2 (de)	1992-04-09	1995-04-20	Ralf Dr Med Kluge	Mittel zur Behandlung der Multiplen Sklerose
WO1994011689A1 (en) *	1992-11-19	1994-05-26	Yu Tom Yen Shing	Paper sheet coating apparatus with gas streams drying
US5405637A (en)	1993-06-30	1995-04-11	Bristol-Myers Squibb Company	Milk protein partial hydrolysate and infant formula containing same
JP3665663B2 (ja)	1994-08-02	2005-06-29	カルピス株式会社	血圧降下剤及びその製造法
CA2260892A1 (en)	1996-07-17	1998-01-22	Nicada, Inc.	Appetite suppression
DE19828114A1 (de) *	1998-06-24	2000-01-27	Probiodrug Ges Fuer Arzneim	Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV
CA2296311A1 (en) *	1999-01-28	2000-07-28	Universite Laval	Enzymatic hydrolysate of milk proteins
EP1034704A1 (de)	1999-03-12	2000-09-13	Societe Des Produits Nestle S.A.	Nahrungszusammensetzung insbesondere für die spezifische gastrointestinale Reifung in frühgeborenen Säugetieren
AU5382200A (en) *	1999-06-15	2001-01-02	University Health Network	Muc1 ligands
US20040152745A1 (en) *	1999-11-12	2004-08-05	Guilford Pharmaceuticals, Inc.	Dipeptidyl peptidase IV inhibitors and methods of making and using dipeptidyl peptidase IV inhibitors
GB9927603D0 (en)	1999-11-22	2000-01-19	Nestle Sa	Use of a milk protein hydrolysate in the treatment of diabetes
AU2000269178A1 (en) *	2000-08-17	2002-02-25	The University Of Texas System	Use of colostrinin, constituent peptides thereof, and analogs thereof as oxidative stress regulators
DE60028575T2 (de)	2000-10-24	2007-06-28	Campina Melkunie B.V.	Peptiden reich an Cystein und/oder Glycin
ATE475324T1 (de)	2000-12-07	2010-08-15	Dsm Ip Assets Bv	Mit carboxy-terminal prolin peptide angereicherte proteinhydrolysate
WO2002071854A1 (en)	2001-03-09	2002-09-19	Unilever N.V.	Fermented milk product
JP2002284668A (ja) *	2001-03-26	2002-10-03	Cosmo Products Kk	クスミの予防・治療剤
FR2825004B1 (fr)	2001-05-22	2005-02-11	Bio Springer	Produit dietetique satiant
RU2003105463A (ru) *	2001-06-27	2004-11-27	Пробиодруг Аг (De)	Пептидные структуры, пригодные для конкурентного модулирования катализа, осуществляемого дипептидилпептидазой iv
US20050013867A1 (en)	2001-10-19	2005-01-20	Lehrman S. Russ	Use of proton sequestering agents in drug formulations
US20030165574A1 (en)	2002-03-01	2003-09-04	Ward Loren Spencer	Compositions and methods for treatment of body weight conditions
US20040009956A1 (en) *	2002-04-29	2004-01-15	Dehua Pei	Inhibition of protein tyrosine phosphatases and SH2 domains by a neutral phosphotyrosine mimetic
EP1367065B1 (de)	2002-05-27	2008-07-30	Nestec S.A.	Säurelösliche Proteine aus Casein-Micellen
ES2540926T3 (es) *	2002-06-04	2015-07-14	Dsm Ip Assets B.V.	Hidrolizado de proteínas rico en tripéptidos
GB0213612D0 (en)	2002-06-13	2002-07-24	Novartis Nutrition Ag	Organic compounds
JP2005538704A (ja)	2002-07-01	2005-12-22	ユニリーバー・ナームローゼ・ベンノートシヤープ	満腹誘導組成物
AU2003264256A1 (en) *	2002-09-04	2004-03-29	Dsm Ip Assets B.V.	A nutritional and therapeutic composition of an insulin sensitizer and a peptide fraction
EP1562623A1 (de)	2002-09-16	2005-08-17	Kerry Group Services Ltd	VERFAHREN ZUR BEHANDLUNG ODER PRÄVENTION VON ADIPOSITAS UND FETTSTOFFWECHSELSTöRUNGEN UND ZUSAMMENSETZUNGEN ZUR VERWENDUNG DARIN
ATE469645T1 (de) *	2002-10-23	2010-06-15	Bristol Myers Squibb Co	Auf glycinnitril basierende hemmer der dipeptidylpeptidase iv
EP1422293A1 (de)	2002-11-25	2004-05-26	F. Hoffmann-La Roche Ag	Kristallstruktur der Dipeptidylpeptidase iV
US20070015269A1 (en) *	2002-11-25	2007-01-18	Michael Hennig	Crystals of DPP-IV
WO2004069265A1 (en)	2003-02-07	2004-08-19	Campina B.V.	Use of tryptophan rich peptides
GB0310593D0 (en)	2003-05-08	2003-06-11	Leuven K U Res & Dev	Peptidic prodrugs
EA200601575A1 (ru) *	2004-03-01	2007-06-29	Пептера Фармасьютикалс Лтд.	Казеиновые пептиды и их терапевтическое применение
EP1753443A1 (de)	2004-05-27	2007-02-21	Campina Nederland Holding B.V.	Verwendung von proteinhydrolysaten zur herstellung eines medikaments zur prophylaxe und/oder behandlung einer dpp-iv-vermittelten erkrankung
EA011865B1 (ru)	2004-07-12	2009-06-30	ДСМ Ай Пи ЭССЕТС Б.В.	Протеиновые гидролизаты, снижающие давление крови
KR101331777B1 (ko)	2004-12-23	2013-11-21	캄피나 네덜란드 홀딩 베.붸.	Ｄｐｐ-ｉｖ를 억제하는 펩타이드가 풍부한 단백질가수분해물 및 이의 용도
JP2009517464A (ja) *	2005-11-30	2009-04-30	カンピーナネーダーランドホールディングビー．ブイ．	グルカゴン様ペプチド１の活性を増強するタンパク質加水分解物の使用

2005
- 2005-11-30 KR KR1020077014235A patent/KR101331777B1/ko not_active Expired - Fee Related
- 2005-11-30 EP EP05809074A patent/EP1831361B1/de not_active Expired - Lifetime
- 2005-11-30 US US11/722,667 patent/US8273710B2/en not_active Expired - Fee Related
- 2005-11-30 WO PCT/NL2005/050056 patent/WO2006068480A2/en not_active Ceased
- 2005-11-30 DK DK05809074.7T patent/DK1831361T3/da active
- 2005-11-30 ES ES05809074T patent/ES2381118T3/es not_active Expired - Lifetime
- 2005-11-30 AT AT05809074T patent/ATE542896T1/de active
- 2005-11-30 JP JP2007548113A patent/JP5068174B2/ja not_active Expired - Fee Related
- 2005-12-01 TW TW094142261A patent/TWI421089B/zh not_active IP Right Cessation
2012
- 2012-09-14 US US13/620,474 patent/US20130096074A1/en not_active Abandoned

Also Published As

Publication number	Publication date
TW200621283A (en)	2006-07-01
EP1831361A2 (de)	2007-09-12
JP5068174B2 (ja)	2012-11-07
US20090075904A1 (en)	2009-03-19
DK1831361T3 (da)	2012-05-14
TWI421089B (zh)	2014-01-01
US20130096074A1 (en)	2013-04-18
KR20070101253A (ko)	2007-10-16
EP1831361B1 (de)	2012-01-25
US8273710B2 (en)	2012-09-25
WO2006068480A3 (en)	2007-01-04
ES2381118T3 (es)	2012-05-23
KR101331777B1 (ko)	2013-11-21
WO2006068480A2 (en)	2006-06-29
JP2008525430A (ja)	2008-07-17

Publication	Publication Date	Title
ATE542896T1 (de)	2012-02-15	Mit dpp-iv hemmenden peptiden angereichertes proteinhydrolysat und deren verwendung
Tacias-Pascacio et al.	2020	Use of Alcalase in the production of bioactive peptides: A review
Hatanaka et al.	2012	Production of dipeptidyl peptidase IV inhibitory peptides from defatted rice bran
Le Gouic et al.	2018	Bioactive peptides from fish protein by-products
Tulipano et al.	2015	Characterisation of the potential of β-lactoglobulin and α-lactalbumin as sources of bioactive peptides affecting incretin function: In silico and in vitro comparative studies
WO1995025749A3 (en)	1995-12-07	Eating suppressant peptides
CY1111322T1 (el)	2015-08-05	Προϊοντα υδρολυσης πρωτεϊνων εμπλουτισμενα σε πεπτιδια που εχουν ενα καρβοξυ-τερματικο υπολειμμα προλινης
PL1898724T3 (pl)	2011-02-28	Preparat odżywczy dla niemowląt z hydrolizowanymi białkami
DE60204714D1 (de)	2005-07-21	Pharmakologische nahrungszusammensetzung zur nahrungsergängzung und nährwertverbesserung
DE602004023210D1 (de)	2009-10-29	Biologisch nicht-abbaubares peptid, inhibitor des angiotensinumwandelnden enzyms, arzneimittel und funktionelles nahrungsmittel
ATE366317T1 (de)	2007-07-15	Herstellung von peptiden und proteinen durch anhäufung in vom endoplasmatischen reticulum abgeleiteten proteinkörpern
WO2010000801A3 (de)	2010-12-09	Molkenproteinhydrolysate enthaltend tryptophanhaltige peptide aus alpha-lactalbumin und deren verwendung
Zhang et al.	2019	Purification and identification of dipeptidyl peptidase IV and angiotensin-converting enzyme inhibitory peptides from silver carp (Hypophthalmichthys molitrix) muscle hydrolysate
Nongonierma et al.	2017	Response surface methodology applied to the generation of casein hydrolysates with antioxidant and dipeptidyl peptidase IV inhibitory properties
UA72915C2 (uk)	2005-05-16	Поживна ентеральна композиція, призначена для підтримки зростання та дозрівання недорозвинених шлунково-кишкових трактів у молодих ссавців та її застосування
WO2003037932A3 (en)	2003-11-27	Human coagulation factor vii polypeptides
WO2007135684A3 (en)	2009-04-23	Method of treatment of anti-cd4 autoimmunity
TW200940080A (en)	2009-10-01	Process for preparing peptide products for promoting cholecystokinin secretion and use of the peptide products
Lydon et al.	1992	Nucleotide and primary amino acid sequence of porcine lactoferrin
WO2005002600A3 (en)	2005-03-31	Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus
GB9917725D0 (en)	1999-09-29	Peptides
WO2006028561A3 (en)	2007-08-30	Novel purified fabi polypeptides from fransicella tularensis
Dong-Min et al.	1992	Angiotensin-I converting enzyme inhibitory activity of enzymatic hydrolysates of mackerel muscle protein
Tan et al.	2022	Tenebrio molitor proteins-derived DPP-4 inhibitory peptides: preparation, identification, and molecular binding mechanism. Foods. 2022; 11 (22): 3626
WO2006097432A3 (de)	2007-04-19	Keratin-biktdende desmoplakinpolypeptidsequenzen